Choosing the right timing for interval debulking surgery and perioperative chemotherapy may improve the prognosis of advanced epithelial ovarian cancer: a retrospective study

• Main Authors: Dengfeng Wang (Author), Guonan Zhang (Author), Chunrong Peng (Author), Yu Shi (Author), Xunwei Shi (Author)
• Format: Knjiga
• Izdano: BMC, 2021-03-01T00:00:00Z.
• Teme: article
• Online dostop: Connect to this object online.

Abstract Background Primary debulking surgery (PDS) is the main treatment for patients with advanced ovarian cancer, and neoadjuvant chemotherapy (NACT) is for bulky stage III-IV patients who are poor surgical candidates and/or for whom there is a low likelihood of optimal cytoreduction. NACT can in...